Intensity-Modulated Radiotherapy for Resected Mesothelioma: The Duke Experience

International Journal of Radiation Oncology Biology Physics

Volumn 71, Issue 4, 2008, Pages 1143-1150

  Miles, Edward F ^a   Larrier, Nicole A ^a   Kelsey, Christopher R ^a   Hubbs, Jessica L ^a   Ma, Jinli ^a   Yoo, Sua ^a   Marks, Lawrence B ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

IMRT; Intensity modulated radiotherapy; Mesothelioma; Pulmonary toxicity

Indexed keywords

BIOLOGICAL ORGANS; DOSIMETERS; DOSIMETRY; ELECTROTHERAPEUTICS; HEALTH; PIGMENTS; RADIOTHERAPY; STATISTICS; TARGETS; TISSUE; TOXICITY; TUMORS;

CHEST WALL; CLINICAL TARGET VOLUME (CVT); DOSIMETRIC PARAMETERS; DUKE UNIVERSITY; EXTRAPLEURAL PNEUMONECTOMY; INTENSITY-MODULATED RADIOTHERAPY (IMRT); LOCAL CONTROL (LC); LUNG VOLUME; MALIGNANT PLEURAL MESOTHELIOMA (MPM); MEAN LUNG DOSE (MLD); MEDICAL CENTERS; PLANNING TARGET VOLUME (PTV); PULMONARY TOXICITY;

PHYSICAL THERAPY;

CISPLATIN; PEMETREXED;

ADULT; AGED; ARTICLE; CANCER CENTER; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; DOSIMETRY; FEMALE; FOLLOW UP; HUMAN; LUNG RESECTION; LUNG TOXICITY; LUNG VOLUME; LYMPH NODE METASTASIS; MALE; MESOTHELIOMA; PNEUMONIA; PRIORITY JOURNAL; RADIATION PNEUMONIA; TREATMENT PLANNING;

AGED; FEMALE; HUMANS; MALE; MESOTHELIOMA; MIDDLE AGED; PLEURAL NEOPLASMS; PNEUMONECTOMY; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, CONFORMAL; TREATMENT OUTCOME;

EID: 45449085014     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.11.011     Document Type: Article

References (22)

1. Robinson B.W., and Lake R.A. Advances in malignant mesothelioma. N Engl J Med 353 (2005) 1591-1603
2. Baldini E.H., Recht A., Strauss G.M., et al. Patterns of failure after trimodality therapy for malignant pleural mesothelioma. Ann Thorac Surg 63 (1997) 334-338
3. Pass H.I., Kranda K., Temeck B.K., et al. Surgically debulked malignant pleural mesothelioma: Results and prognostic factors. Ann Surg Oncol 4 (1997) 215-222
4. Ahamad A., Stevens C.W., Smythe W.R., et al. Intensity-modulated radiation therapy: A novel approach to the management of malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 55 (2003) 768-775
5. Allen A.M., Czerminska M., Janne P.A., et al. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma. Int J Radiat Oncol Biol Phys 65 (2006) 640-645
6. Forster K.M., Smythe W.R., Starkschall G., et al. Intensity-modulated radiotherapy following extrapleural pneumonectomy for the treatment of malignant mesothelioma: Clinical implementation. Int J Radiat Oncol Biol Phys 55 (2003) 606-616
7. Ismail-Khan R., Robinson L.A., Williams Jr. C.C., et al. Malignant pleural mesothelioma: A comprehensive review. Cancer Control 13 (2006) 255-263
8. Stahel R.A. Malignant pleural mesothelioma: A new standard of care. Lung Cancer 54 Suppl. 2 (2006) S9-S14
9. van Ruth S., Baas P., and Zoetmulder F.A. Surgical treatment of malignant pleural mesothelioma: A review. Chest 123 (2003) 551-561
10. Zellos L.S., and Sugarbaker D.J. Multimodality treatment of diffuse malignant pleural mesothelioma. Semin Oncol 29 (2002) 41-50
11. Vogelzang N.J., Rusthoven J.J., Symanowski J., et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 21 (2003) 2636-2644
12. Rusch V.W., Rosenzweig K., Venkatraman E., et al. A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 122 (2001) 788-795
13. Treasure T., Tan C., Lang-Lazdunski L., et al. The MARS trial: Mesothelioma and radical surgery. Interact Cardiovasc Thorac Surg 5 (2006) 58-59
14. Chan P., Yeo I., Perkins G., et al. Dosimetric comparison of intensity-modulated, conformal, and four-field pelvic radiotherapy boost plans for gynecologic cancer: A retrospective planning study. Radiat Oncol 1 (2006) 13
15. Christian J.A., Bedford J.L., Webb S., et al. Comparison of inverse-planned three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 67 (2007) 735-741
16. Cozzi L., Fogliata A., Bolsi A., et al. Three-dimensional conformal vs. intensity-modulated radiotherapy in head-and-neck cancer patients: Comparative analysis of dosimetric and technical parameters. Int J Radiat Oncol Biol Phys 58 (2004) 617-624
17. Harsolia A., Kestin L., Grills I., et al. Intensity-modulated radiotherapy results in significant decrease in clinical toxicities compared with conventional wedge-based breast radiotherapy. Int J Radiat Oncol Biol Phys 68 (2007) 1375-1380
18. Milano M.T., Jani A.B., Farrey K.J., et al. Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: Toxicity and clinical outcome. Int J Radiat Oncol Biol Phys 63 (2005) 354-361
19. Zelefsky M.J., Chan H., Hunt M., et al. Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer. J Urol 176 (2006) 1415-1419
20. Gregory D.L., Fairfoul J., Chantler H., et al. Intensity modulated radiotherapy to deliver hemithorax irradiation for mesothelioma for the MARS trial. Clin Oncol (R Coll Radiol) 19 (2007) S30
21. Rice D.C., Smythe W.R., Liao Z., et al. Dose-dependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 69 (2007) 350-357
22. Brunelli A., Sabbatini A., Xiume F., et al. A model to predict the decline of the forced expiratory volume in one second and the carbon monoxide lung diffusion capacity early after major lung resection. Interact Cardiovasc Thorac Surg 4 (2005) 61-65